Literature DB >> 20655905

Doxycycline suppresses doxorubicin-induced oxidative stress and cellular apoptosis in mouse hearts.

Hui-Chin Lai1, Yueh-Chiao Yeh, Chih-Tai Ting, Wen-Lieng Lee, Hsiao-Wei Lee, Li-Chuan Wang, Kuo-Yang Wang, Hui-Chun Lai, Angie Wu, Tsun-Jui Liu.   

Abstract

Cardiac toxicity remains a serious yet unsolved complication of doxorubicin. This study was designed to examine whether doxycycline, a tetracycline-derived synthetic antibiotic with potential cytoprotective properties, could ameliorate this complication of doxorubicin. Male mice at 4-week of age were administrated with vehicle, doxorubicin (3mg/kg intraperitoneally every other day at 3 doses), doxycycline (2.5mg/kg intraperitoneally every other day for 3 doses), or doxycycline plus doxorubicin (each dose given 1day post doxycycline). After 28days, left ventricular geometric and systolic parameters were measured by transthoracic echocardiography, and hearts were harvested for extensive analyses regarding oxidative stress and cellular apoptosis. At 28days, hearts of doxorubicin-treated mice were characterized by less weight compared with controls, also with remodeling and depressed systolic function of the left ventricle. Biochemical analyses disclosed that content of malondialdehyde was increased and activity of antioxidant enzymes, including superoxide dismutase and glutathione peroxidase, was decreased in these hearts. Both mitochondrion-dependent and endoplasmic reticulum stress-induced apoptotic pathways were also activated in the hearts of doxorubicin-treated mice as reflected by decreased Bcl-2/Bcl-(XL) and elevated Bax/Bad, p53/Apaf-1, endoplasmic reticulum glucose-related protein 78, C/EBP homologous protein, cytochrome c release from mitochondria, caspases-9/-3 cleavage, and cardiomyocyte apoptosis. In contrast, all the above left ventricular remodeling, systolic depressing, oxidative and pro-apoptotic actions of doxorubicin could be significantly alleviated by doxycycline pretreatment. Thus, doxycycline extensively counteracts multiple oxidative and apoptotic actions of doxorubicin in heart, hence may serve as an adjuvant agent to assuage the untoward cardiac effects of doxorubicin in clinical application. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20655905     DOI: 10.1016/j.ejphar.2010.07.010

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  20 in total

1.  Antioxidant effect of doxycycline decreases MMP activity and blood pressure in SHR.

Authors:  Raquel C Antonio; Carla S Ceron; Elen Rizzi; Eduardo B Coelho; Jose E Tanus-Santos; Raquel F Gerlach
Journal:  Mol Cell Biochem       Date:  2013-10-10       Impact factor: 3.396

2.  Autophagy induced by deficiency of sphingosine-1-phosphate phosphohydrolase 1 is switched to apoptosis by calpain-mediated autophagy-related gene 5 (Atg5) cleavage.

Authors:  Sandrine Lépine; Jeremy C Allegood; Yvette Edmonds; Sheldon Milstien; Sarah Spiegel
Journal:  J Biol Chem       Date:  2011-11-03       Impact factor: 5.157

3.  Hydrogen sulfide protects H9c2 cells against doxorubicin-induced cardiotoxicity through inhibition of endoplasmic reticulum stress.

Authors:  Xiu-Yu Wang; Chun-Tao Yang; Dong-Dan Zheng; Li-Qiu Mo; Ai-Ping Lan; Zhan-Li Yang; Fen Hu; Pei-Xi Chen; Xin-Xue Liao; Jian-Qiang Feng
Journal:  Mol Cell Biochem       Date:  2011-12-28       Impact factor: 3.396

4.  Prevention of Doxorubicin cardiopathic changes by a benzyl styryl sulfone in mice.

Authors:  Min Lu; Salim Merali; Ronald Gordon; Jiandong Jiang; Yan Li; John Mandeli; Xunbao Duan; John Fallon; James F Holland
Journal:  Genes Cancer       Date:  2011-10

5.  MMP inhibitors attenuate doxorubicin cardiotoxicity by preventing intracellular and extracellular matrix remodelling.

Authors:  Brandon Y H Chan; Andrej Roczkowsky; Woo Jung Cho; Mathieu Poirier; Consolato Sergi; Vic Keschrumrus; Jared M Churko; Henk Granzier; Richard Schulz
Journal:  Cardiovasc Res       Date:  2021-01-01       Impact factor: 10.787

6.  Doxycycline attenuates cisplatin-induced acute kidney injury through pleiotropic effects.

Authors:  Terumasa Nakagawa; Yutaka Kakizoe; Yasunobu Iwata; Yoshikazu Miyasato; Teruhiko Mizumoto; Masataka Adachi; Yuichiro Izumi; Takashige Kuwabara; Naoki Suenaga; Yuki Narita; Hirofumi Jono; Hideyuki Saito; Kenichiro Kitamura; Masashi Mukoyama
Journal:  Am J Physiol Renal Physiol       Date:  2018-07-25

7.  Doxorubicin and NRG-1/erbB4-Deficiency Affect Gene Expression Profile: Involving Protein Homeostasis in Mouse.

Authors:  Cecilia Vasti; Henning Witt; Matilde Said; Patricia Sorroche; Hernán García-Rivello; Patricia Ruiz-Noppinger; Cecilia M Hertig
Journal:  ISRN Cardiol       Date:  2012-08-29

8.  Chemotherapy-induced late transgenerational effects in mice.

Authors:  Loro L Kujjo; Eun A Chang; Ricardo J G Pereira; Shilpa Dhar; Brenda Marrero-Rosado; Satyaki Sengupta; Hongbing Wang; Jose B Cibelli; Gloria I Perez
Journal:  PLoS One       Date:  2011-03-17       Impact factor: 3.240

9.  Flavaglines alleviate doxorubicin cardiotoxicity: implication of Hsp27.

Authors:  Yohann Bernard; Nigel Ribeiro; Frédéric Thuaud; Gülen Türkeri; Ronan Dirr; Mounia Boulberdaa; Canan G Nebigil; Laurent Désaubry
Journal:  PLoS One       Date:  2011-10-31       Impact factor: 3.240

10.  Molecular effects of doxycycline treatment on pterygium as revealed by massive transcriptome sequencing.

Authors:  Ignacio M Larráyoz; Alberto de Luis; Oscar Rúa; Sara Velilla; Juan Cabello; Alfredo Martínez
Journal:  PLoS One       Date:  2012-06-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.